cigna glp 1 coverage reaches new deal on Eli Lilly and Novo Nordisk weight loss drugs Cigna CEO on medicare advantage
Description
As shown in Figure 2
Semaglutide is the same active ingredient used in three products marketed by Novo Nordisk: Ozempic, Rybelsus, and Wegovy
GLP-1s interact with receptors in the brain to promote satiety and reduce appetite, making individuals feel fuller for longer periods and helping to manage weight
Calcium + D3: As weight loss occurs, bone density is a key consideration
